Tally Health and Cenegenics Forge a New Era of Personalized Longevity Care

A New Approach to Longevity Care

The collaboration between Tally Health™ and Cenegenics marks a significant milestone in personalized longevity health care. Tally Health, a biotechnology innovator committed to extending the healthspan, has partnered with Cenegenics, a leader in age management and performance health, to deliver next-generation aging insights and solutions more widely.

This partnership introduces the TallyAge™ Test, a breakthrough in epigenetic age testing. This test evaluates over 200,000 DNA methylation sites through a simple, non-invasive cheek swab. The advantage of the TallyAge™ Test lies in its rigorous foundation, trained with data from the largest DNA methylation cheek swab dataset available globally—over 8,000 individuals aged from 18 to 100 years, including a significant diversity of over 30% non-white participants. The accuracy and comprehensiveness of the test empower individuals to understand their cellular age and the impact of life choices on health through easily digestible insights.

Cenegenics patients now benefit from this cutting-edge technology as part of their preventive care strategies. Regular updates regarding their aging trajectories will assist in optimizing personal health strategies over time.

In addition to the TallyAge™ Test, this collaboration showcases Tally Health’s science-backed pro-longevity supplements, which are designed to enhance energy, bolster mitochondrial function, and promote cellular health. These innovative supplements will be accessible throughout Cenegenics’ national network of physician-led centers, providing a broader scope of nutraceutical options tailored for individuals engaged in proactive aging management.

"This partnership combines the best of two organizations deeply committed to transforming the way we age," states Melanie Goldey, CEO of Tally Health. "Together, we're advancing personalized, science-driven care that empowers individuals to understand their aging and make meaningful changes to extend their healthspan."

The synergy of Tally Health and Cenegenics is poised to elevate the standard for personalized health care by integrating cutting-edge epigenetic testing and supplements into a patient-centered model. Kristy Berry, CEO of Cenegenics, echoes this sentiment: "Cenegenics has long led the field in precision, performance-driven preventive medicine. Our collaboration with Tally Health brings forward innovative tools that empower personal health management and track biological aging holistically."

This partnership is not only about immediate patient benefits but extends its reach into joint research initiatives to evaluate the efficacy of interventions that utilize the TallyAge™ Test. This research will accumulate insights that deepen our understanding of aging biology and yield better, personalized health interventions.

Tally Health remains focused on developing holistic wellness solutions that address the underlying biological processes responsible for aging. The journey begins with a vision of transparency, quality, and individual empowerment, aiming to aid people in taking control of their aging process.

On the other end of the spectrum, Cenegenics stands tall as the authority in precision performance health, with over 30 years of clinical expertise. Their bespoke diagnostic and treatment programs cater to individual needs, further enhancing resilience and vitality. Both companies share a dedication to not just extending lifespan but improving quality of life across all stages of aging.

For more information about the offerings and details on how this partnership will reshape longevity strategies, visit tallyhealth.com and cenegenics.com.